Abstract: Proteomic technology has been widely used in the research of medical sciences, including the study of the pathogenesis of carcinoma, discovery and identification of novel biomarkers and evaluating the response to treatment, as well as in the application of early diagnosis, clinical pathologic stages and screening therapeutic targets in cervical carcinoma. In the aspect of cervical carcinoma, many reports have demonstrated the differently expressed proteins from the proteome level, and these results provide reliable theoretic base for well understanding of the diagnosis and treatment in cervical carcinoma.